Who
Scott M. Giacobello
Chief Financial Officer
Company insider
Files Form 4 as: Chief Financial Officer, Whitehawk Therapeutics; Chief Financial Officer, Gw Pharmaceuticals.
In numbers
- Trades disclosed
- 89
- Buys
- 1
- Sells
- 8
- Bought
- $49K
- Sold
- $2.0M
- Companies
- 2
- Companies where not an officer
- 0
- First trade
- 26 Feb 2019
- Last trade
- 15 Sep 2026
- Last filed
- 18 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 15 Sep 2026filed 18 Sep 2026 | WHWK Whitehawk Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —118,476 at $0.00 | filing |
| 15 Sep 2026filed 18 Sep 2026 | WHWK Whitehawk Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —118,476 at $0.00 | filing |
| 15 Sep 2026filed 18 Sep 2026 | WHWK Whitehawk Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —118,476 at $0.00 | filing |
| 15 Sep 2026filed 18 Sep 2026 | WHWK Whitehawk Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —118,476 at $0.00 | filing |
| 15 Sep 2026filed 15 Sep 2026 | WHWK Whitehawk Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —118,476 at $0.00 | filing |
| 15 Sep 2026filed 15 Sep 2026 | WHWK Whitehawk Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —118,476 at $0.00 | filing |
| 15 Sep 2026filed 15 Sep 2026 | WHWK Whitehawk Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —118,476 at $0.00 | filing |
| 15 Sep 2026filed 15 Sep 2026 | WHWK Whitehawk Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —118,476 at $0.00 | filing |
| 14 May 2026filed 18 May 2026 | WHWK Whitehawk TherapeuticsBiotechnology | SEC FORM 4 Code A | $150K38,265 at $3.92 | filing |
| 14 May 2026filed 18 May 2026 | WHWK Whitehawk TherapeuticsBiotechnology | SEC FORM 4 Code A | $150K38,265 at $3.92 | filing |
| 16 Apr 2026filed 17 Apr 2026 | WHWK Whitehawk TherapeuticsBiotechnology | SEC FORM 4 Sold | $585K141,600 at $4.13 | filing |
| 16 Apr 2026filed 17 Apr 2026 | WHWK Whitehawk TherapeuticsBiotechnology | SEC FORM 4 Sold | $585K141,600 at $4.13 | filing |
| 15 Apr 2026filed 17 Apr 2026 | WHWK Whitehawk TherapeuticsBiotechnology | SEC FORM 4 Sold | $297K77,000 at $3.86 | filing |
| 15 Apr 2026filed 17 Apr 2026 | WHWK Whitehawk TherapeuticsBiotechnology | SEC FORM 4 Sold | $297K77,000 at $3.86 | filing |
| 1 Apr 2026filed 3 Apr 2026 | WHWK Whitehawk TherapeuticsBiotechnology | SEC FORM 4 Code M | —473,902 | filing |
| 1 Apr 2026filed 3 Apr 2026 | WHWK Whitehawk Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —473,902 at $0.00 | filing |
| 1 Apr 2026filed 3 Apr 2026 | WHWK Whitehawk Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —300,677 at $0.00 | filing |
| 1 Apr 2026filed 3 Apr 2026 | WHWK Whitehawk Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —473,902 at $0.00 | filing |
| 1 Apr 2026filed 3 Apr 2026 | WHWK Whitehawk Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —300,677 at $0.00 | filing |
| 1 Apr 2026filed 3 Apr 2026 | WHWK Whitehawk TherapeuticsBiotechnology | SEC FORM 4 Code M | —473,902 | filing |
News
Financial Review: Whitehawk Therapeutics (NASDAQ:WHWK) and BeyondSpring (NASDAQ:BYSI)WHWK · dailypolitical.com · 17 Oct 2026Head to Head Analysis: Whitehawk Therapeutics (NASDAQ:WHWK) vs. Surrozen (NASDAQ:SRZN)WHWK · dailypolitical.com · 10 Oct 2026
0 headlines in the last 90 days name Scott M. Giacobello; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.